OOIR: Observatory of International Research

Papers

(The H4-Index of Neuropsychopharmacology is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Pramipexole modulates fronto-subthalamic pathway in sequential working memory	803
Role of neuropeptide neuromedin U in the nucleus accumbens shell in cocaine self-administration in male rats	374
A new prism next to motherhood’s light: uncovering changes in neural function following childbirth	359
Fentanyl-induced hyperalgesia and analgesic tolerance in male rats: common underlying mechanisms and prevention by a polyamine deficient diet	198
ACNP 62nd Annual Meeting: Keyword Index	182
Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine	171
The National Institute on Drug Abuse Summer Research Internship Program: Building a Diverse National Scientific Workforce	162
Using metabolic imaging to investigate neuromodulatory mechanisms of rTMS	151
Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model	144
Targeted and transient opening of the blood brain barrier in discrete neurocircuits and brain regions	137
A sex-specific role for the bed nucleus of the stria terminalis in proactive defensive behavior	134
Delayed estrogen actions diminish food consumption without changing food approach, motor activity, or hypothalamic activation elicited by corticostriatal µ-opioid signaling	131
Distinct roles of excitatory and inhibitory neurons in the medial prefrontal cortex in the expression and reconsolidation of methamphetamine-associated memory in male mice	120
Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitement	103
Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy	102
ACNP 61st Annual Meeting: Poster Abstracts P541 – P809	98
Prefrontal allopregnanolone mediates the adverse effects of acute stress in a mouse model of tic pathophysiology	95
Parvalbumin interneuron mGlu5 receptors govern sex differences in prefrontal cortex physiology and binge drinking	90
Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect	84
Leveraging ultra-high field (7T) MRI in psychiatric research	83
Sensitive period-regulating genetic pathways and exposure to adversity shape risk for depression	80
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders	77
Data-driven connectivity profiles relate to smoking cessation outcomes	73
Hippocampus and amygdala fear memory engrams re-emerge after contextual fear relapse	72
Validation of a non-food or water motivated effort-based foraging task as a measure of motivational state in male mice	72

It’s about racism, not race: a call to purge oppressive practices from neuropsychiatry and scientific discovery	70
Inhibition of striatal indirect pathway during second postnatal week leads to long-lasting deficits in motivated behavior	67
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios	66
Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study	64
Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes	63
The GABAA receptor modulator zolpidem augments hippocampal-prefrontal coupling during non-REM sleep	61
Gestational ethanol exposure impairs motor skills in female mice through dysregulated striatal dopamine and acetylcholine function	58
Leveraging large-scale brain networks in rats to understand neurological and psychiatric disorders in humans	57
Prefrontal-hippocampal interactions supporting the extinction of emotional memories: the retrieval stopping model	56
Altered neuronal activity in the ventromedial prefrontal cortex drives nicotine intake escalation	55
A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of	55
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner	55
Towards an understanding of psychedelic-induced neuroplasticity	55
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward	54
Sex differences in offspring risk and resilience following 11β-hydroxylase antagonism in a rodent model of maternal immune activation	54
A path to novel, effective treatments for schizophrenia	54
Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis	54
IN MEMORIAM John Gary Csernansky 1954–2022	54
Optogenetic inhibition of the dorsal hippocampus CA3 region during early-stage cocaine-memory reconsolidation disrupts subsequent context-induced cocaine seeking in rats	53
Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial	53
In Memoriam: Larry J. Young, PhD	51
Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility	51
Correction to: Nucleus accumbens D1-receptors regulate and focus transitions to reward-seeking action	51
NPP Editorial: tides of progress	51
In Memoriam: Dr. James B. Appel	49